US Congress backs appeals system for Medicare decisions
This article was originally published in Clinica
Executive Summary
A US House of Representatives panel will take up legislation this week that would streamline the process for appealing decisions made by Medicare, the federal health plan for the elderly and the disabled. The Medicare Patient Appeals Act was introduced last year but was never acted upon. It has now been included in the House Republican's version of a Medicare prescription drug benefit bill.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.